Menstrual and reproductive factors and gastric cancer risk in a large prospective study of women

Freedman, Neal D.; Wong-Ho Chow; Yu-Tang Gao; Xiao-Ou Shu; Bu-Tian Ji; Gong Yang; Lubin, Jay H.; Hong-Lan Li; Rothman, Nathaniel; Wei Zheng; Abnet, Christian C.
December 2007
Gut;Dec2007, Vol. 56 Issue 12, p1671
Academic Journal
Background: Gastric cancer incidence rates are consistently lower in women than men in both high and low-risk regions worldwide. Sex hormones, such as progesterone and estrogen, may protect women against gastric cancer. Objective: To investigate the association of menstrual and reproductive factors and gastric cancer risk. Methods: These associations were prospectively investigated in 73 442 Shanghai women. After 419 260 person-years of follow-up, 154 women were diagnosed with gastric cancer. Hazard ratios (HR) and 95% confidence intervals (CI) were calculated using Cox proportional hazards models adjusted for age, body mass index, education, income, and cigarette use. Results: No associations were observed between gastric cancer risk and age of menarche, number of children, breast feeding, or oral contraceptive use. In contrast, associations were observed with age of menopause (HR 0.80 per five-year increase in menopausal age, 95% CI 0.66-0.97), years of fertility (participants with less than 30 years of fertility were at increased risk compared with those with 30-36 years of fertility, HR 1 .90, 95% CI 1.25-2.90), years since menopause (HR 1.26 per five years, 95% CI 1.03-1.53), and intrauterine device use (HR for users 1.61, 95% CI 1.08-2.39). Conclusions: These results support the hypothesis that female hormones play a protective role in gastric cancer risk.


Related Articles

  • Body mass index and survival after breast cancer diagnosis in Japanese women. Kawai, Masaaki; Minami, Yuko; Nishimo, Yoshikazu; Fakumachi, Kayoko; Ohuchi, Noriaki; Kagugawa, Yoichiro // BMC Cancer;2012, Vol. 12 Issue 1, p149 

    Background: Body mass index (BMI) may be an important factor affecting breast cancer outcome. Studies conducted mainly in Western countries have reported a relationship between higher BMI and a higher risk of all-cause death or breast cancer-specific death among women with breast cancer, but...

  • Effect of Adiposity and Fat Distribution on Endometrial Cancer Risk in Shanghai Women. Wang Hong Xu; Matthews, Charles E.; Yong Bing Xiang; Wei Zheng; Zhi Xian Ruan; Jia Rong Cheng; Yu Tang Gao; Xiao Ou Shu // American Journal of Epidemiology;May2005, Vol. 161 Issue 10, p939 

    The authors conducted a population-based case-control study of 832 endometrial cancer cases and 846 frequency-matched controls in Shanghai, China (1997–2001), to examine the association of overall adiposity and body fat distribution with disease risk. Overall adiposity was estimated using...

  • Associations of Body Composition Measures and Endogenous Sex-Steroid Hormones among Postmenopausal Women. Mellemkjaer, Lene; Christensen, Jane; Frederiksen, Kirsten; Olsen, Anja; Bennett, Paul; Overvad, Kim; Tjønneland, Anne // Open Obesity Journal;2011, Vol. 3, p51 

    Several studies have shown a positive association between body mass index (BMI) and endogenous levels of female sex-steroid hormones, but relationship with the body fat mass and the fat free mass components of BMI has rarely been investigated. In this cross-sectional study, we included 265 women...

  • Circulating Sex Steroids, Sex Hormone-Binding Globulin, and Longitudinal Changes in Forearm Bone Mineral Density in Postmenopausal Women and Men: The Tromsø Study. Bjørnerem, Åshild; Emaus, Nina; Berntsen, Gro; Joakimsen, Ragnar M.; Fønnebø, Vinjar; Wilsgaard, Tom; Øian, Pål; Seeman, Ego; Straume, Bjørn // Calcified Tissue International;Aug2007, Vol. 81 Issue 2, p65 

    Bone loss during advancing age in women and men is partly the result of sex steroid deficiency. As the contribution of circulating sex steroids and sex hormone-binding globulin (SHBG) to bone loss remains uncertain, we sought to determine whether levels of sex steroids or SHBG predict change in...

  • Recall of Early Menstrual History and Menarcheal Body Size: After 30 Years, How Well Do Women Remember? Must, A.; Phillips, S. M.; Naumova, E. N.; Blum, M.; Harris, S.; Dawson-Hughes, B.; Rand, W. M. // American Journal of Epidemiology;Vol. 155 Issue 7, p672 

    The validity of recall of early menstrual characteristics is of interest because of their putative role in the etiology of breast cancer and other diseases. A retrospective follow-up of the Newton Girls Study (1965-1975) provided an opportunity to assess the accuracy and precision of recall of...

  • Lifestyle Factors, Hormonal Contraception, and Premenstrual Symptoms: The United Kingdom Southampton Women's Survey. Sadler, Carrie; Smith, Helen; Hammond, Julia; Bayly, Rosie; Borland, Sharon; Panay, Nick; Crook, David; Inskip, Hazel // Journal of Women's Health (15409996);Mar2010, Vol. 19 Issue 3, p391 

    Objective: To estimate the prevalence of premenstrual symptoms in women from the general population in Southampton, U.K., and examine their association with lifestyle factors and contraceptive use. Methods: This was a cross-sectional survey in the city of Southampton, U.K., of 974 women aged...

  • Inverse relationship between body mass index and premenopausal breast cancer risk in Malaysian women. Kandiah, M.; Tan, P. C. J. // Asia Pacific Journal of Clinical Nutrition;2004 Supplement, Vol. 13, pS171 

    Human breast cancer is usually categorized as either premenopausal or postmenopausal. The epidemiological evidence for the role of anthropometric factors, specifically body mass index, in the etiology of breast cancer has become clearer and stronger particularly for populations in developed...

  • A review of hormonal changes during the menopausal transition: focus on findings from the Melbourne Womens Midlife Health Project. H.G. Burger; G.E. Hale; D.M. Robertson; L. Dennerstein // Human Reproduction Update;Nov2007, Vol. 13 Issue 6, p559 

    The menopause, defined as the permanent cessation of menstruation resulting from the loss of ovarian follicular activity, marks the end of natural female reproductive life. It is preceded by a period of menstrual cycle irregularity, the menopausal transition, which usually begins in the mid-40s...

  • Hormonal status determines the treatment of hormone-related headache in women.  // Drugs & Therapy Perspectives;Jan2007, Vol. 23 Issue 1, p14 

    The prevalence of migraine in women appears to be affected by life-cycle changes in levels of female sex hormones. Migraines commonly occur in the perimenstrual period, and often improve during pregnancy and after menopause. Acute and preventive migraine treatments are available. The hormonal...


Read the Article


Sign out of this library

Other Topics